US EditionPublished • loading... • Updated
Parkinson's Disease: Continuous L-Dopa Therapy Improves Symptoms in Real-World Conditions
Summary by Deutsches Ärzteblatt
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Bottrop/Berlin – Real-world data from Germany show significant improvements in motor and non-motor symptoms in people with Parkinson's disease after six months of continuous subcutaneous therapy with foslevodopa/foscarbidopa. This was reported by the German research group of the ongoing ROSSINI study ("Real-world Outcomes with...").
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
